P
PAVmed Inc. (PAVM)
NCM – Real Time Price. Currency in USD
6.50
-0.25 (-3.70%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
6.50
-0.25 (-3.70%)
At close: May 12, 2026, 4:00 PM EDT
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company’s lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck device. Its product pipeline also comprises EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
| Name | Position |
|---|---|
| Dr. Brian J. deGuzman M.D. | Executive VP, Chief Technology & Compliance Officer |
| Dr. Deepika A. Lakhani Ph.D. | Senior VP, Chief Regulatory & Quality Officer |
| Dr. Lishan Aklog M.D. | Chairman & CEO |
| Dr. Suman M. Verma M.D., Ph.D. | Senior VP of Molecular Genetics & Chief Scientific Officer |
| Dr. Victoria T. Lee M.D. | Executive Vice President & Chief Medical Officer |
| Mr. Joseph Virgilio | SVP & Chief Business Officer of Medical Devices |
| Mr. Matthew Riley | Senior Director of Investor Relations |
| Mr. Michael Adam Gordon | Executive VP, General Counsel & Secretary |
| Mr. Shaun M. O'Neill M.B.A. | Executive VP & COO |
| Date | Type | Document |
|---|---|---|
| 2026-04-30 | DEF 14A | formdef14a.htm |
| 2026-04-21 | S-3 | forms-3.htm |
| 2026-04-02 | S-8 | forms-8.htm |
| 2026-03-30 | 8-K | form8-k.htm |
| 2026-03-27 | 10-K | pavm20251231_10k.htm |
| 2026-02-24 | DEF 14A | formdef14a.htm |
| 2026-02-17 | D | |
| 2026-02-13 | PRE 14A | formpre14a.htm |
| 2026-02-04 | 8-K | form8-k.htm |
| 2026-01-23 | 8-K | form8-k.htm |